Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00
Titel:
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00
Auteur:
Fountzilas, G. Dafni, U. Gogas, H. Linardou, H. Kalofonos, H.P. Briasoulis, E. Pectasides, D. Samantas, E. Bafaloukos, D. Stathopoulos, G.P. Karina, M. Papadimitriou, C. Skarlos, D. Pisanidis, N. Papakostas, P. Markopoulos, C. Tzorakoeleftherakis, E. Dimitrakakis, K. Makrantonakis, P. Xiros, N. Polichronis, A. Varthalitis, I. Karanikiotis, C. Dimopoulos, A.M.